Delasos, Lukas
Khorrami, Mohammadhadi
Viswanathan, Vidya S.
Jazieh, Khalid
Ding, Yifu
Mutha, Pushkar
Stephans, Kevin
Gupta, Amit
Pennell, Nathan A.
Patil, Pradnya D.
Higgins, Kristin
Madabhushi, Anant https://orcid.org/0000-0002-5741-0399
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA202752-01A1, R01CA208236-01A1, R01CA220581-01A1)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (1R43EB028736-01)
U.S. Department of Health & Human Services | NIH | National Center for Research Resources (1 C06 RR12463-01)
California Breast Cancer Research Program (W81XWH-19-1-0668)
Foundation for the National Institutes of Health (P50CA217691)
Article History
Received: 1 August 2024
Accepted: 17 December 2024
First Online: 24 December 2024
Competing interests
: Dr. Madabhushi is an equity holder in Picture Health, Elucid Bioimaging, and Inspirata Inc. Currently he serves on the advisory board of Picture Health, and SimBioSys. He also currently consults for SimBioSys and Takeda. He also has sponsored research agreements with AstraZeneca and Bristol Myers-Squibb. His technology has been licensed to Picture Health and Elucid Bioimaging. He is also involved in 2 different R01 grants with Inspirata Inc. He also serves as a member for the Frederick National Laboratory Advisory Committee. All other authors do not have any financial or non-financial interests.